Skip to main content
  • Jan 15, 2020

    Anti-VEGF Therapy in Patients with Neovascular AMD

    American Academy of Ophthalmology,
    Learning Plan CME
    2.5 Self-Assessment AMA PRA Category 1 Credits™

    This learning plan, based on IRIS Registry measure IRIS45: Exudative Age-Related Macular Degeneration: Loss of Visual Acuity, reviews the impact of anti-VEGF injections in patients with wet age-related macular degeneration (AMD), including genetic predictive biomarkers of anti-VEGF treatment responses.

      Funded in part by the Retina Research Foundation